News

According to Integra LifeSciences, Coral extended tab spinal screws are designed for applications where the extent of the vertebral misalignment would not allow a standard sized tab pedicle

The company currently has agreements with 60 investigational sites in the US for Phase III trials of NX-1207, and expects the number of clinical trial sites to be

The company has recently announced results from its Phase II study and intends to initiate a Phase III clinical program in this indication in the second half of

This Phase IIb trial is an important milestone for Oramed as it will test its first indication for ORMD-0801 on a large group of volunteers for the duration

Under the terms of the agreement Sigmar will pay Stellar an upfront licensee fee, plus a specified transfer price in exchange for the rights to an exclusive license

This Phase II, randomized, double-blind, placebo-controlled study to be conducted at multiple sites in the US and Europe, will evaluate the safety and efficacy of three 28-day, once-daily,

The first quarter 2009 gross profit improvement represented an increase of 67% over the comparable period in 2008 and was due primarily to medical device sales. Operating expenses

Perceptive Informatics, an eClinical solutions provider and a subsidiary of Parexel International, has developed a new medical imaging methodology for central nervous system clinical trials involving Alzheimer’s disease.

BioTime, a biotechnology company, has reported that the California Institute for Regenerative Medicine, or CIRM, has approved a grant to the company of $4.7m to fund research related